Blake Insomnia Therapeutics competitors

Blake Insomnia Therapeutics's competitors include AbbVie, Soligenix, Vifor Pharma and Sol-Gel Technologies
Add company...
Blake Insomnia Therapeutics
Blake Insomnia Therapeutics is a pharmaceutical company.
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Soligenix
Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.
Vifor Pharma
Vifor Pharma is a diversified group active throughout the healthcare market which, among other things, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks.
Sol-Gel Technologies
Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.
Founding Date
Founding Date
2012
Founding Date
2013
Founding Date
1987
Founding Date
1927
Founding Date
1997
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Locations
North Chicago, US HQ
Ludwigshafen, DE
Sligo, IE
Cork, IE
Campoverde, IT
Tokyo, JP
Jayuya, PR
see more
Locations
Princeton, US HQ
Locations
Bern, CH HQ
Locations
Ness Ziona, IL HQ
Employees
Employees
6
Employees
29,000
Employees
28
Employees
5,9919% decrease
Employees
50
Valuation ($)
Valuation ($)
2.8 m
Valuation ($)
148.7 b
Valuation ($)
24.2 m
Valuation ($)
N/A
Valuation ($)
118.4 m
Facebook likes
Facebook likes
N/A
Facebook likes
11.9 k
Facebook likes
229
Facebook likes
88
Facebook likes
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
48.3 k
Twitter followers
523
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$25.6b (FY, 2016)
Revenue (est.)
$5.4m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$5.8b (FY, 2016)
Cost of goods
$4.3m (FY, 2017)
Cost of goods
N/A
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$19.8b (FY, 2016)
Gross profit
$1.1m (FY, 2017)
Gross profit
N/A
Gross profit
N/A
Net income
Net income
N/A
Net income
$6b (FY, 2016)
Net income
($7.1m) (FY, 2017)
Net income
N/A
Net income
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

AbbVie
HQ
North Chicago, US
Employees
29,000

AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.

View company
Soligenix
HQ
Princeton, US
Employees
28

Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases.

View company
Vifor Pharma
HQ
Bern, CH
Employees
5,991↓ 9% decrease

Vifor Pharma is a diversified group active throughout the healthcare market which, among other things, develops, manufactures and markets pharmaceutical products, runs pharmacies, provides logistical and database services and sets up networks.

View company
Sol-Gel Technologies
HQ
Ness Ziona, IL
Employees
50

Sol-Gel Technologies is engaged in the development of a range of specialty pharmaceuticals.

View company